Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma
出版年份 2014 全文链接
标题
Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma
作者
关键词
-
出版物
Blood Cancer Journal
Volume 4, Issue 10, Pages e250-e250
出版商
Springer Nature
发表日期
2014-10-10
DOI
10.1038/bcj.2014.69
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
- (2014) J. Martinez-Lopez et al. BLOOD
- Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study
- (2013) Joaquin Martinez-Lopez et al. BRITISH JOURNAL OF HAEMATOLOGY
- Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry
- (2013) N Puig et al. LEUKEMIA
- Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
- (2013) M Ladetto et al. LEUKEMIA
- Overview of clinical flow cytometry data analysis: recent advances and future challenges
- (2013) Carlos E. Pedreira et al. TRENDS IN BIOTECHNOLOGY
- Minimal Residual Disease in Myeloma: Are We There Yet?
- (2012) Andrew J. Hart et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients
- (2012) Raija Silvennoinen et al. BRITISH JOURNAL OF HAEMATOLOGY
- EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
- (2012) J J M van Dongen et al. LEUKEMIA
- Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
- (2011) S. V. Rajkumar et al. BLOOD
- Comparison of Immunofixation, Serum Free Light Chain, and Immunophenotyping for Response Evaluation and Prognostication in Multiple Myeloma
- (2011) Bruno Paiva et al. JOURNAL OF CLINICAL ONCOLOGY
- Depth of response assessed by quantitative ASO-PCR predicts the outcome after stem cell transplantation in multiple myeloma
- (2010) Mervi Putkonen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents
- (2010) C. Fernandez de Larrea et al. HAEMATOLOGICA
- Abnormal serum free light chain ratio in patients with multiple myeloma in complete remission has strong association with the presence of oligoclonal bands: implications for stringent complete remission definition
- (2009) C. F. de Larrea et al. BLOOD
- The role of complete response in multiple myeloma
- (2009) J.-L. Harousseau et al. BLOOD
- The relationship between the serum free light chain assay and serum immunofixation electrophoresis, and the definition of concordant and discordant free light chain ratios
- (2009) S. Singhal et al. BLOOD
- Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma
- (2008) Tomer Mark et al. BRITISH JOURNAL OF HAEMATOLOGY
- Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
- (2008) A. C. Rawstron et al. HAEMATOLOGICA
- International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
- (2008) A Dispenzieri et al. LEUKEMIA
- Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
- (2008) R A Kyle et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More